Oral acyclovir therapy of recurrent herpes simplex virus type 2 infection of the hand.
Acyclovir was evaluated as treatment of recurrent herpes simplex virus type 2 infection of the hand in a double-blind, placebo-controlled crossover study. In nine fully evaluable patients, oral acyclovir (2 g/day in three doses for 10 days) initiated during the earliest phase of a recurrence reduced...
שמור ב:
| הוצא לאור ב: | Antimicrob Agents Chemother |
|---|---|
| Principais autores: | , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
American Society for Microbiology (ASM)
1991
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC245012/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/1850971/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.35.2.382 |
| תגים: |
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|